Ongos, Baby Boy .
HRN: 25-98-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/07/2024
10/14/2024
IV
38
Q24h
Bacterial Meningitis
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes